Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eton Pharmaceuticals, Inc. - Common Stock
(NQ:
ETON
)
61.81
+0.08 (+0.13%)
Streaming Delayed Price
Updated: 12:04 PM EDT, Aug 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eton Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
August 14, 2026
Via
Chartmill
Why Eton Pharmaceuticals Is Top of the Class Today
↗
August 14, 2026
Eton's cure for an expensive valuation: a 99% sales growth rate.
Via
The Motley Fool
Keep an eye on the top gainers and losers in Friday's session.
↗
August 14, 2026
Via
Chartmill
Friday's session: gap up and gap down stocks
↗
August 14, 2026
Via
Chartmill
Eton Pharmaceuticals (NASDAQ:ETON) Soars on Q1 Beat, Raises Full-Year Guidance
↗
May 14, 2026
Via
Chartmill
Eton Pharmaceuticals (NASDAQ:ETON) Posts Mixed Q4 2025 Results with Revenue Beat and EPS Miss
↗
March 19, 2026
Via
Chartmill
Discover the top movers in Friday's pre-market session.
↗
August 14, 2026
Via
Chartmill
Eton Pharmaceuticals Q2 Earnings Call Highlights
↗
August 13, 2026
Eton Pharmaceuticals (NASDAQ:ETON) reported second-quarter revenue nearly doubled from a year earlier, driven by the relaunch of HEMANGEOL and growth across its pediatric endocrinology and rare-disease...
Via
MarketBeat
Topics
Earnings
Eton Pharmaceuticals Q2 2026 Earnings Call: Complete Transcript
↗
August 13, 2026
Eton Pharmaceuticals (NASDAQ:ETON) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. Benzinga APIs provide...
Via
Benzinga
Topics
Earnings
Stay updated with the stocks that are on the move in today's after-hours session.
↗
August 13, 2026
Via
Chartmill
Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results
August 13, 2026
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001
August 05, 2026
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
August 03, 2026
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI® (hydrocortisone) Oral Solution
July 29, 2026
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)
May 19, 2026
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton (ETON) Q1 2026 Earnings Call Transcript
↗
May 15, 2026
Eton (ETON) Q1 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Eton Pharmaceuticals Q1 Earnings Call Highlights
↗
May 14, 2026
Eton Pharmaceuticals (NASDAQ:ETON) raised its 2026 revenue outlook after reporting record first-quarter product sales and highlighting early progress from two recent product launches, DESMODA and...
Via
MarketBeat
Topics
Earnings
Eton Pharmaceuticals Reports First Quarter 2026 Financial Results
May 14, 2026
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals to Participate in Upcoming Investor Conferences
May 12, 2026
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
May 04, 2026
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution
May 01, 2026
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700
April 27, 2026
-- Company’s extended-release formulation of zinc acetate will be compared to GALZIN® (zinc acetate) and a placebo for the treatment of Wilson disease --
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals Announces CFO Succession Plan
April 16, 2026
Experienced pharmaceutical executive Judith M. Matthews to assume CFO role on June 1st
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharma (ETON) Earnings Call Transcript
↗
March 19, 2026
Eton Pharma (ETON) Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
March 19, 2026
From
Eton Pharmaceuticals
Via
GlobeNewswire
Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing
↗
March 04, 2026
Immunome develops antibody therapeutics for cancer and infectious diseases, reporting a market cap above $2 billion in the latest filing.
Via
The Motley Fool
Topics
Regulatory Compliance
Investment Manager Sells $5.1 Million Worth of LQDA Stock, According to Recent SEC Filing
↗
March 04, 2026
Liquidia develops inhaled and injectable therapies for pulmonary arterial hypertension, targeting unmet needs in the U.S. biopharma market.
Via
The Motley Fool
Topics
Regulatory Compliance
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026
March 03, 2026
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution
March 02, 2026
From
Eton Pharmaceuticals
Via
GlobeNewswire
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA™ (desmopressin acetate) Oral Solution
February 25, 2026
From
Eton Pharmaceuticals
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
